Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03157323 · ClinicalTrials.gov registry record · NA
Low GI Diet in Children and Adolescents With ALL
A NA study of Acute Lymphoblastic Leukemia, Pediatric and Obesity, Pediatric, sponsored by Columbia University.
- Active
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 5
- Study locations
NCT03157323 is a NA study of Acute Lymphoblastic Leukemia, Pediatric and Obesity, Pediatric that is active but no longer recruiting, run by Columbia University. The registered enrollment target is 88 participants, below the 113-participant average among 8 other Acute Lymphoblastic Leukemia, Pediatric trials with a reported enrollment target (22% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT03157323, a NA study of Acute Lymphoblastic Leukemia, Pediatric and Obesity, Pediatric, is active but no longer recruiting, sponsored by Columbia University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 5
- Study locations
Study Summary
The study aims to determine the feasibility of a 6-month low glycemic dietary intervention in children and adolescents undergoing treatment for acute lymphoblastic leukemia.
Conditions Studied
Interventions
- BEHAVIORAL Low Glycemic Index Diet
Study Locations (5)
New York
- Roswell Park Cancer Institute - Buffalo
- Columbia University - New York
Connecticut
- Connecticut Children's Medical Center - Hartford
District of Columbia
- Children's National Hospital - Washington D.C.
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03157323
The ClinicalTrials.gov registry entry for NCT03157323 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 113-participant average among 8 other Acute Lymphoblastic Leukemia, Pediatric trials with a reported enrollment target (22% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Lymphoblastic Leukemia, Pediatric appearing as the primary indexed condition, and to 1 intervention - of which Low Glycemic Index Diet is the first listed.
NCT03157323 reports 5 study locations spanning 4 distinct geographic areas - top geographies include New York, Connecticut, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT03157323 about?
NCT03157323 is a clinical study titled "Low GI Diet in Children and Adolescents With ALL". The study aims to determine the feasibility of a 6-month low glycemic dietary intervention in children and adolescents undergoing treatment for acute lymphoblastic leukemia.
What is the current status of trial NCT03157323?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 88 participants. The study started on 2017-06-01. Estimated completion is 2026-06.
What conditions does trial NCT03157323 study?
This clinical trial studies the following conditions: Acute Lymphoblastic Leukemia, Pediatric, Obesity, Pediatric.
What interventions are being tested in trial NCT03157323?
The interventions under investigation include: Low Glycemic Index Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT03157323?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03157323 being conducted?
This trial has 5 study locations across Connecticut, District of Columbia, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Lymphoblastic Leukemia, Pediatric
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
RECRUITING · NA
-
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
RECRUITING · NA
-
Massage Impact on Sleep in Pediatric Oncology
RECRUITING · NA
-
Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
RECRUITING · NA
-
Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)
RECRUITING · Phase 1
-
CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies
ACTIVE NOT RECRUITING · Phase 1
Explore more on PlainTrial
Acute Lymphoblastic Leukemia, Pediatric
All registered trials for this condition
Obesity, Pediatric
All registered trials for this condition
Connecticut
All trials with a study site in Connecticut
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.